Brief: Herantis Pharma To Expand Phase 2 AdeLE Clinical Trial

Herantis Pharma Oyj

28/03/2019 07:20

March 28 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * REG-HERANTIS PHARMA ANNOUNCES EXPANSION OF ITS PHASE 2
STUDY
ADELE IN BREAST CANCER ASSOCIATED LYMPHEDEMA WITH TWO CENTERS IN
SWEDEN
    * ADELE STUDY WILL ALSO CONTINUE TO RECRUIT PATIENTS AT
THREE
UNIVERSITY HOSPITALS IN FINLAND.

Source text for Eikon:  ID:nGNE2MyHm7 
Further company coverage:  HRTIS.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))